CD274 and intrahepatic cholangiocarcinoma: In addition, this PD-L1− M1/PD-L1− M2 TAM combination biomarker stratification strategy surpasses all the immune biomarkers examined above in distinguishing the prognosis of ICC (p = 0.0001).